Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma-Reference-Cited by-同舟云学术

Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma

Published:2022-01-27 Issue:3 Volume:12 Page:615-629
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Morita Akimichi^ORCID,Tateishi Chiharu,Ikumi Kyoko,Hayashi Daisuke,Nakada Aya,Nishihara Haruna,Torii Kan,Nishida Emi,Tsuruta Daisuke

Funder

Minophagen Pharmaceutical Co., Ltd

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-021-00655-0.pdf

Reference21 articles.

1. Dores GM, Anderson WF, Devesa SS. Cutaneous lymphomas reported to the national cancer institute’s surveillance, epidemiology, and end results program: applying the new WHO-European organization for research and treatment of cancer classification system. J Clin Oncol. 2005;23:7246–8.

2. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–85.

3. Zackheim HS, Vonderheid EC, Ramsay DL, LeBoit PE, Rothfleisch J, Kashani-Sabet M. Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol. 2000;43:793–6.

4. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood. 2006;107:265–76.

5. Aoki R, Karube K, Sugita Y, et al. Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001–2006. Pathol Int. 2008;58:174–82.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Body Mass Index on Hypertriglyceridemia Associated with Oral Bexarotene Therapy: A Post Hoc Analysis of an Open-Label Comparative Clinical Study of Combined Bexarotene and Phototherapy Versus Bexarotene Monotherapy for Japanese Patients with Cutaneous T-Cell Lymphoma;Drugs in R&D;2024-06

2. Skin-directed therapy and biologic response modifiers in mycosis fungoides;Dermatology Reports;2024-05-07

3. Light exposure and its applications in human health;Journal of Biophotonics;2024-04-04

4. Traitements immunomodulateurs du mycosis fongoïde aux stades précoces;Annales de Dermatologie et de Vénéréologie - FMC;2023-04

5. Phototherapy combined with systemic agents for mycosis fungoides;Vestnik dermatologii i venerologii;2023-01-27